Year archive

RADIOPHARM THERANOSTICS LIMITED — 2025 filings

All 93 regulatory filings released by RADIOPHARM THERANOSTICS LIMITED (RAD) in 2025, sourced directly from the official regulator.

93 Filings

2025 Period

2025 filings (93)

Filing	Released	Lang
Notification of cessation of securities - RAD 4 pages 15.0KB Regulatory Filings	2025-12-22	English
Notification regarding unquoted securities - RAD 6 pages 19.4KB Share Issue/Capital Change	2025-12-18	English
Change of Director's Interest Notice (IT) 3 pages 240.6KB Director's Dealing	2025-12-18	English
Change of Director's Interest Notice (PH) 3 pages 241.1KB Director's Dealing	2025-12-18	English
Change of Director's Interest Notice (RC) 3 pages 241.2KB Director's Dealing	2025-12-18	English
Non-compliance with ASX Listing Rule 7.1 2 pages 92.0KB Regulatory Filings	2025-12-17	English
RAD announces establishment of At-The-Market Equity Facility 3 pages 269.9KB Capital/Financing Update	2025-12-17	English
Proposed issue of securities - RAD 5 pages 17.4KB Capital/Financing Update	2025-12-17	English
RAD101 interim Phase 2b data - 92% achieve primary endpoint 3 pages 293.6KB Capital/Financing Update	2025-12-14	English
Ceasing to be a substantial holder PH 2 pages 178.4KB Major Shareholding Notification	2025-12-09	English
New Class Options Range of Units and Top 20 Holders 3 pages 147.1KB Major Shareholding Notification	2025-12-08	English
Application for quotation of securities - RAD 7 pages 22.4KB Share Issue/Capital Change	2025-12-08	English
Application for quotation of securities - RAD 8 pages 24.9KB Capital/Financing Update	2025-12-08	English
Notice Under Section 708A 1 page 81.0KB Share Issue/Capital Change	2025-12-08	English
Application for quotation of securities - RAD 6 pages 18.5KB Share Issue/Capital Change	2025-12-04	English
Share purchase plan completed 2 pages 131.9KB Capital/Financing Update	2025-12-02	English
Results of Meeting 2 pages 93.9KB Declaration of Voting Results & Voting Rights Announcements	2025-12-02	English
Ceasing to be a substantial holder 3 pages 210.0KB Major Shareholding Notification	2025-11-30	English
Final Director's Interest Notice - LA 2 pages 1.1MB Director's Dealing	2025-11-24	English
Final Director's Interest Notice - PH 2 pages 1.1MB Director's Dealing	2025-11-24	English
Notification of cessation of securities - RAD 4 pages 15.0KB Share Issue/Capital Change	2025-11-24	English
Presentation to Annual General Meeting 22 pages 1.1MB Investor Presentation	2025-11-19	English
Results of Meeting 3 pages 286.6KB Declaration of Voting Results & Voting Rights Announcements	2025-11-19	English
Life Sciences Leader Bruce Goodwin Appointed to Board 2 pages 237.9KB Board/Management Information	2025-11-18	English
Initial Director's Interest Notice 2 pages 292.8KB Director's Dealing	2025-11-18	English
RAD Approval for Phase 1 Therapeutic Trial of RAD 402 2 pages 114.8KB Regulatory Filings	2025-11-17	English
RAD Announces 50% Enrollment in Phase 2b Trial of RAD101 3 pages 120.5KB Capital/Financing Update	2025-11-16	English
RAD starts enrollment of 3rd Cohort of Phase 1 177Lu-RAD204 2 pages 116.1KB Regulatory Filings	2025-11-11	English
Disclosure of Long Equity Derivative Positions 3 pages 194.1KB Major Shareholding Notification	2025-11-05	English
Notice of Extraordinary General Meeting and Proxy Form 18 pages 315.3KB Proxy Solicitation & Information Statement	2025-11-03	English
Change of Director's Interest Notice (RC) 3 pages 509.3KB Director's Dealing	2025-11-02	English
Presenting at Deutsche Bank ADR Virtual Investor Conference 3 pages 241.8KB Investor Presentation	2025-11-02	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 1.7MB Interim / Quarterly Report	2025-10-27	English
Change in substantial holding 3 pages 235.6KB Major Shareholding Notification	2025-10-27	English
Change in substantial holding PH 3 pages 116.6KB Major Shareholding Notification	2025-10-27	English
Change in substantial holding 4 pages 297.8KB Major Shareholding Notification	2025-10-27	English
Share Purchase Plan - Now Open 2 pages 720.8KB Capital/Financing Update	2025-10-23	English
Application for quotation of securities - RAD 6 pages 18.5KB Share Issue/Capital Change	2025-10-23	English
Notice Under Section 708A 1 page 528.9KB Regulatory Filings	2025-10-23	English
Notice of Annual General Meeting/Proxy Form 39 pages 1.0MB AGM Information	2025-10-21	English
RAD completes A$35 M Placement and launches A$5 M SPP 7 pages 226.5KB Capital/Financing Update	2025-10-19	English
Proposed issue of securities - RAD 5 pages 18.2KB Capital/Financing Update	2025-10-19	English
Proposed issue of securities - RAD 8 pages 27.3KB Capital/Financing Update	2025-10-19	English
Proposed issue of securities - RAD 6 pages 22.1KB Capital/Financing Update	2025-10-19	English
RAD Provides Positive Clinical Updates Across Four Programs 4 pages 153.1KB Capital/Financing Update	2025-10-19	English
Investor Presentation - Clinical Update and Capital Raising 54 pages 2.9MB Investor Presentation	2025-10-19	English
Prospectus 53 pages 779.6KB Capital/Financing Update	2025-10-19	English
Target market determination (TMD) 3 pages 113.2KB Regulatory Filings	2025-10-19	English
Trading Halt 2 pages 207.4KB Capital/Financing Update	2025-10-14	English
Notification regarding unquoted securities - RAD 6 pages 19.4KB Share Issue/Capital Change	2025-10-06	English
Radiopharm received approval for RAD 202 trial acceleration 2 pages 255.1KB Regulatory Filings	2025-09-30	English
SPL:Research & Option Agreement with Radiopharm Theranostics 4 pages 177.1KB Capital/Financing Update	2025-09-29	English
Radiopharm Theranostics Partners with Starpharma on Research 3 pages 283.1KB Capital/Financing Update	2025-09-29	English
Annual Report and Form 20-F 189 pages 3.1MB Annual Report	2025-09-16	English
Corporate Governance Statement and Appendix 4G 19 pages 1.1MB Governance Information	2025-09-16	English
Pivalate (Brain Mets) key opinion leader webinar 3 pages 114.3KB Regulatory Filings	2025-09-14	English
Appendix 4E and Preliminary Final Report 16 pages 1.3MB Interim / Quarterly Report	2025-08-28	English
Radiopharm to host key opinion leader webinar series 3 pages 144.8KB Regulatory Filings	2025-08-20	English
Notification regarding unquoted securities - RAD 6 pages 19.2KB Share Issue/Capital Change	2025-07-31	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 5.4MB Annual Report	2025-07-28	English
RAD receives IND approval from US FDA for Betabart (RV-01) 2 pages 109.5KB Capital/Financing Update	2025-07-27	English
Dr Oliver Sartor appointed to RAD Scientific Advisory Board 2 pages 106.5KB Board/Management Information	2025-07-21	English
Radiopharm Receives $4.5M R&D Tax Incentive 2 pages 89.9KB Regulatory Filings	2025-07-15	English
RAD and Cyclotek Sign Supply Agreement for 161Tb-KLK3-mAb 2 pages 109.4KB Capital/Financing Update	2025-06-23	English
Change in substantial holding 5 pages 280.8KB Major Shareholding Notification	2025-06-15	English
Application for quotation of securities - RAD 6 pages 18.6KB Share Issue/Capital Change	2025-06-11	English
Notice Under Section 708A 1 page 80.5KB Capital/Financing Update	2025-06-11	English
RAD Granted US FDA Fast Track for RAD101 Metastases Imaging 2 pages 113.6KB Regulatory Filings	2025-06-10	English
Proposed issue of securities - RAD 5 pages 17.3KB Capital/Financing Update	2025-06-09	English
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 2 pages 119.0KB Regulatory Filings	2025-06-03	English
RAD Reports Positive Preclinical Lu177-B7H3-mAb Data 3 pages 277.7KB Capital/Financing Update	2025-06-01	English
Change of Director's Interest Notice (IT) 3 pages 239.1KB Director's Dealing	2025-05-29	English
ITM and RAD Sign Supply Agreement for n.c.a. Lutetium-177 2 pages 128.3KB Capital/Financing Update	2025-05-18	English
Acceleration of RAD204 Phase 1 dose escalation trial 2 pages 217.0KB Regulatory Filings	2025-05-11	English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 5.5MB Interim / Quarterly Report	2025-04-28	English
First patient dosed in Phase IIb imaging for Brain Mets 3 pages 221.3KB Regulatory Filings	2025-04-27	English
New RAD202 data confirms positive tumor uptake 2 pages 210.1KB Capital/Financing Update	2025-03-16	English
Participation in Leerink, NWR healthcare conferences 2 pages 194.3KB Regulatory Filings	2025-03-12	English
Notification regarding unquoted securities - RAD 6 pages 18.7KB Share Issue/Capital Change	2025-03-06	English
Update - Notification regarding unquoted securities - RAD 6 pages 18.4KB Share Issue/Capital Change	2025-03-06	English
Half Year Report and Appendix 4D 31 December 2024 44 pages 1.9MB Interim / Quarterly Report	2025-02-27	English
Change of Director's Interest Notice (IT) 3 pages 214.5KB Director's Dealing	2025-02-24	English
Notification of cessation of securities - RAD 5 pages 16.1KB Share Issue/Capital Change	2025-02-24	English
RAD to present at TD Cowen Annual Healthcare Conference 2 pages 148.6KB Investor Presentation	2025-02-23	English
Participation in B Riley Securities Radiopharma Conference 2 pages 162.1KB Regulatory Filings	2025-02-17	English
Clinical trial data shows RAD 101 detects Brain Metastases 3 pages 228.1KB Regulatory Filings	2025-02-09	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 1.1MB Interim / Quarterly Report	2025-01-29	English
Change in substantial holding 6 pages 520.3KB Major Shareholding Notification	2025-01-22	English
Change in substantial holding 15 pages 809.2KB Regulatory Filings	2025-01-21	English
Application for quotation of securities - RAD 6 pages 19.2KB Capital/Financing Update	2025-01-20	English
Notice Under Section 708A 1 page 133.3KB Capital/Financing Update	2025-01-20	English
Response to ASX Cleansing Notice Validity Letter 5 pages 926.3KB Regulatory Filings	2025-01-19	English
Lantheus increases shareholding in RAD with A$8m placement 2 pages 93.6KB Capital/Financing Update	2025-01-09	English